Composition, form of production and packaging
Cream for external application of white color, homogeneous.
1 g
beclomethasone (in the form of dipropionate) 250 Ојg
clotrimazole 10 mg
Excipients: benzyl alcohol, white petrolatum, paraffin liquid, cetomacrogol, propylene glycol, methyl parahydroxybenzoate, propyl parahydroxybenzoate, butylhydroxytoluene, sodium phosphate anhydrous, sodium dihydrogen phosphate, purified water.
15 g - aluminum tubes (1) - cardboard packs.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2008.
PHARMACHOLOGIC EFFECT
Combination drug for external use. Clotrimazole is a derivative of imidazole. Disrupts the synthesis of ergosterol, which is part of the cell membrane of fungi, which causes a change in its properties and leads to lysis of the cell. Beclomethasone is a glucocorticoid, it has anti-inflammatory, anti-allergic, antiexudative, antipruritic effect.
The drug is active against dermatophytes (Trichophyton, Epidermophyton, Microsporum), yeast and yeast-like fungi (Candida, Torulopsis, Rhodoturola), mold fungi, as well as Malassezia furfur, Aspergillus; some strains of gram-positive bacteria (Streptococcus spp., Staphylococcus spp., Corynebacterium minutissimum), gram-negative bacteria (Bacteroides spp., Gardnerella vaginalis), and Trichomonas vaginalis.
PHARMACOKINETICS
Data on the pharmacokinetics of Candide B are not available.
INDICATIONS
Skin mycoses (including those complicated by acute eczematous symptoms):
- dermatomycosis of various parts of the body;
- epidermophytia of the feet;
- Dermatoses complicated by a secondary infection.
DOSING MODE
Before applying the cream, rinse and dry the affected area. The cream should be applied directly to the affected areas, providing direct contact of the drug with the skin, including. on the hairy areas of the body. The drug is used 2-3 times / day.
After the disappearance of eczematous symptoms, it is recommended to switch to treatment with Candide cream until the primary fungal infection disappears completely.
SIDE EFFECT
Local reactions: redness of the skin, burning sensation and tingling at the site of application (with development of irritation, the drug should be discarded).
Possible: allergic reactions.
CONTRAINDICATIONS
- specific skin lesions (including tuberculosis, chicken pox, simple herpes, measles, syphilis);
- skin reactions at the vaccination site;
- Hypersensitivity to the components of the drug.
PREGNANCY AND LACTATION
The safety of Candida B during pregnancy and lactation is not established. Therefore, the administration of the drug in large quantities or for a long time in these periods should be avoided.
SPECIAL INSTRUCTIONS
The drug is intended for use only in dermatological practice.
The use of Candida B as part of the complex therapy of candidiasis of the anogenital area allows to quickly achieve a significant improvement in the patient's condition.
It should be noted that with the external application of glucocorticoids on large areas of the skin or with occlusive dressings, their systemic absorption is possible.
When using occlusive dressings, it is possible to develop rash, folliculitis, pyoderma.
OVERDOSE
Acute overdose with external application of Candida B is unlikely.
DRUG INTERACTION
Drug interaction of Candida B is not described.
TERMS OF RELEASE FROM PHARMACY
The drug is released by prescription.
TERMS AND CONDITIONS OF STORAGE
The drug should be stored in a dry, dark place at a temperature below 25 В° C. Shelf life - 3 years.
